BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing

Robert E. Carraway, Sankar P. Mitra, B. Mark Evers, Courtney Townsend

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Antisera towards the bioactive peptides, neurotensin (NT, 13 residues) and neuromedin N (NMN, 6 residues), as well as towards three regions of their 147-residue canine precursor were used to identify and to quantitate precursor-derived peptides in extracts of human BON cells. This cell-line, which was obtained from a human pancreatic carcinoid tumor, constituitively expresses NT/NMN mRNA and secretes NT. Quantitation of seven precursor-derived peptides led us to conclude that BON cells display the intestinal pattern of NT/NMN precursor processing, which is primarily characterized by the production of a large molecular (125 amino acid) form of NMN. Four large molecular components, identified by immunochemical analyses and Western blotting, displayed physico-chemical properties which, for the most part, were consistent with the structures predicted from the partially-known human mRNA sequence. However, as shown previously for these peptides in canine gut, the empirically determined Mr and pI values were slightly higher than those predicted solely from the amino acid content, perhaps due to the presence of additional substituents. These results suggest that BON cells may provide a good in vitro model in which to study the regulation of intestinal NT/NMN precursor processing and the nature of the enzyme(s) involved.

Original languageEnglish
Pages (from-to)17-29
Number of pages13
JournalRegulatory Peptides
Volume53
Issue number1
DOIs
StatePublished - Aug 31 1994

Fingerprint

Neurotensin
Peptides
neuromedin N
Processing
Canidae
Amino Acids
Messenger RNA
Carcinoid Tumor
Chemical properties
Tumors
Immune Sera
Western Blotting
Cell Line
neuromedin N precursor
Enzymes

Keywords

  • BON cell
  • Neuromedin N
  • Neurotensin
  • Precursor-processing

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing. / Carraway, Robert E.; Mitra, Sankar P.; Evers, B. Mark; Townsend, Courtney.

In: Regulatory Peptides, Vol. 53, No. 1, 31.08.1994, p. 17-29.

Research output: Contribution to journalArticle

Carraway, Robert E. ; Mitra, Sankar P. ; Evers, B. Mark ; Townsend, Courtney. / BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing. In: Regulatory Peptides. 1994 ; Vol. 53, No. 1. pp. 17-29.
@article{8f9656741eee4917aeb4dfebbc14077d,
title = "BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing",
abstract = "Antisera towards the bioactive peptides, neurotensin (NT, 13 residues) and neuromedin N (NMN, 6 residues), as well as towards three regions of their 147-residue canine precursor were used to identify and to quantitate precursor-derived peptides in extracts of human BON cells. This cell-line, which was obtained from a human pancreatic carcinoid tumor, constituitively expresses NT/NMN mRNA and secretes NT. Quantitation of seven precursor-derived peptides led us to conclude that BON cells display the intestinal pattern of NT/NMN precursor processing, which is primarily characterized by the production of a large molecular (125 amino acid) form of NMN. Four large molecular components, identified by immunochemical analyses and Western blotting, displayed physico-chemical properties which, for the most part, were consistent with the structures predicted from the partially-known human mRNA sequence. However, as shown previously for these peptides in canine gut, the empirically determined Mr and pI values were slightly higher than those predicted solely from the amino acid content, perhaps due to the presence of additional substituents. These results suggest that BON cells may provide a good in vitro model in which to study the regulation of intestinal NT/NMN precursor processing and the nature of the enzyme(s) involved.",
keywords = "BON cell, Neuromedin N, Neurotensin, Precursor-processing",
author = "Carraway, {Robert E.} and Mitra, {Sankar P.} and Evers, {B. Mark} and Courtney Townsend",
year = "1994",
month = "8",
day = "31",
doi = "10.1016/0167-0115(94)90155-4",
language = "English",
volume = "53",
pages = "17--29",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing

AU - Carraway, Robert E.

AU - Mitra, Sankar P.

AU - Evers, B. Mark

AU - Townsend, Courtney

PY - 1994/8/31

Y1 - 1994/8/31

N2 - Antisera towards the bioactive peptides, neurotensin (NT, 13 residues) and neuromedin N (NMN, 6 residues), as well as towards three regions of their 147-residue canine precursor were used to identify and to quantitate precursor-derived peptides in extracts of human BON cells. This cell-line, which was obtained from a human pancreatic carcinoid tumor, constituitively expresses NT/NMN mRNA and secretes NT. Quantitation of seven precursor-derived peptides led us to conclude that BON cells display the intestinal pattern of NT/NMN precursor processing, which is primarily characterized by the production of a large molecular (125 amino acid) form of NMN. Four large molecular components, identified by immunochemical analyses and Western blotting, displayed physico-chemical properties which, for the most part, were consistent with the structures predicted from the partially-known human mRNA sequence. However, as shown previously for these peptides in canine gut, the empirically determined Mr and pI values were slightly higher than those predicted solely from the amino acid content, perhaps due to the presence of additional substituents. These results suggest that BON cells may provide a good in vitro model in which to study the regulation of intestinal NT/NMN precursor processing and the nature of the enzyme(s) involved.

AB - Antisera towards the bioactive peptides, neurotensin (NT, 13 residues) and neuromedin N (NMN, 6 residues), as well as towards three regions of their 147-residue canine precursor were used to identify and to quantitate precursor-derived peptides in extracts of human BON cells. This cell-line, which was obtained from a human pancreatic carcinoid tumor, constituitively expresses NT/NMN mRNA and secretes NT. Quantitation of seven precursor-derived peptides led us to conclude that BON cells display the intestinal pattern of NT/NMN precursor processing, which is primarily characterized by the production of a large molecular (125 amino acid) form of NMN. Four large molecular components, identified by immunochemical analyses and Western blotting, displayed physico-chemical properties which, for the most part, were consistent with the structures predicted from the partially-known human mRNA sequence. However, as shown previously for these peptides in canine gut, the empirically determined Mr and pI values were slightly higher than those predicted solely from the amino acid content, perhaps due to the presence of additional substituents. These results suggest that BON cells may provide a good in vitro model in which to study the regulation of intestinal NT/NMN precursor processing and the nature of the enzyme(s) involved.

KW - BON cell

KW - Neuromedin N

KW - Neurotensin

KW - Precursor-processing

UR - http://www.scopus.com/inward/record.url?scp=0028025283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028025283&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(94)90155-4

DO - 10.1016/0167-0115(94)90155-4

M3 - Article

VL - 53

SP - 17

EP - 29

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1

ER -